Annual report pursuant to Section 13 and 15(d)

Revenue Recognition - Schedule of Revenue Recognition (Details)

v3.20.1
Revenue Recognition - Schedule of Revenue Recognition (Details) - USD ($)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Total revenues $ 11,216,937 $ 7,353,266
Product - Functional Neurosurgery    
Total revenues 6,884,085 5,313,041
Product - Biologics and Drug Delivery    
Total revenues 1,458,850 913,424
Products - Therapy    
Total revenues 96,925  
Product - Capital Equipment    
Total revenues 1,036,505 420,039
Product - Product Revenue    
Total revenues 9,476,365 6,685,020
Services - Biologics and Drug Delivery    
Total revenues 889,702 175,223
Service - Therapy    
Total revenues 225,000 100,000
Services - Capital Equipment and Other    
Total revenues 625,870 393,023
Services - Service Revenue    
Total revenues $ 1,740,572 $ 668,246